Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-05-07

FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for labetalol hydrochloride related to this product, signaling an update or expansion of its regulatory approval for use…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

SUPPL AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)